There is some intriguing data suggesting that GIP, at least in animals, mitigates some of the adverse events that can be induced by GLP-1, says Drucker
Semaglutide has significant effects on several blood work markers, and anyone on an active protocol needs to understand what changes to expect and why
So, those are the elements being one of the reasons why the oral weight loss was able to scale so quickly
Novo in October 2024 took the extra step of arguing to the FDA that semaglutide is too complex to compound, asking the regulator to include the drug in its Demonstrable Difficulties for Compounding (DDC) listin turn keeping it out of reach for compounders even in times of shortage
Buzzetti, R., Maddaloni, E., Gaglia, J., Leslie, R
Yes, it may interact with anticonvulsant medications